News provided by Novo Nordisk Nov 17, 2025, 07:45 ET For a limited time, patients in the US can get the first two doses of authentic, FDA-approved Wegovy and Ozempic for only $199 each beginning November 17, 2025 Also effective November 17, Novo Nordisk is lowering the price of Wegovy and Ozempic for existing self-pay patients in the US from $499 to $349 per month* Self-pay pricing available through 70,000+ pharmacies nationwide, home delivery, and select telehealth providers These offers build on Novo Nordisk's ongoing efforts to expand access to FDA-approved semaglutide medicines across the many different channels patients use to get their prescriptions PLAINSBORO, N.J., Nov
Bob decides to make a 5% contribution to his post-tax retirement plan
Without it, your body often reverts to its baseline metabolism
Ozempic, also marketed as Wegovy for weight management, contains the active drug semaglutide
The Benefits of Microdosing GLP-1: Well Beyond Weight Loss 1